Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2004-05-24
2008-08-05
Bausch, Sarae (Department: 1634)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C536S023100
Reexamination Certificate
active
07407753
ABSTRACT:
The present invention uncovers a highly significant association of SNPs in the CNR2 locus, encoding the cannabinoid receptor 2 protein, with osteoporosis. Methods and kits for determining predisposition to osteoporosis, improving diagnosis in individuals suspected of having osteoporosis are provided. Also provided a method of identifying a putative osteoporosis-causing genetic mutation in a subject.
REFERENCES:
patent: 0451867 (1991-10-01), None
patent: WO 92/14481 (1992-03-01), None
patent: WO 92/15712 (1992-09-01), None
patent: WO 2004/103410 (2004-02-01), None
Munro, Sean et al. Molecular characterization of a peripheral receptor for cannabinoids. 1993. Nature. vol. 365 pp. 61-65.
Devoto, Marcella et al. Variance component linkage analysis indicates a QTL for femoral neck bone mineral density of chromosome 1p36. 2001 Human Molecular Genetics vol. 10 No. 21 pp. 2447-2452.
Wacholder, Sholom et al. Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. Journal of the National Cancer Institute. 2004. vol. 96 pp. 434-442.
Abrams et al. “Comprehensive Detection of Single Base Changes in Human Genomic DNA Using Denaturing Gradient Gel Electrophoresis and A GC Clamp”, Genomics, 7: 463-475, 1990.
Abravaya et al. “Molecular Beacons as Diagnostic Tools: Technology and Applications”, Clin. Chem. Lab. Med., 41(4): 468-474, 2003.
Iwamura et al. “In Vitro and In Vivo Pharmacological Characterization of JTE-907, A Novel Selective Ligand for Cannabinoid CB2 Receptor”, The Journal of Pharmacological and Experimental Therapeutics, 296(2): 420-425, 2001.
Writing Group “Diagnosis of Osteoporosis in Men, Premenopausal Woman, and Children”, The Writing Group for the ISCD Position Development Conference, Journal of Clinical Densitometry, 7(1): 17-26, 2004.
Larrick, et al. “PCR Amplification of Antibody Genes”, Methods: A Comparison to Methods in Enzymology, 2(2): 106-110, 1991.
Latorra et al. “Enhanced Allele-Specific PCR Discrimination in SNP Genotyping Using 3′ Locked Nucleic Acid (LNA) Primers”, Human Mutation, 22: 79-85, 2003.
Liljedahl et al. “A Microarray Minisequencing System for Pharmacogenetic Profiling of Antihypertensive Drug Response”, Pharmacogenetics, 13: 7-17, 2003.
Day et al. “High-Throughput Genotyping Using Horizontal Polyacrylamid Gels With Wells Arranged for Microplate Array Diagonal Gel Electrophoresis (MADGE)”, BioTechniques, 19: 830-835, 1995.
Manolagas et al. “Sex Steroids, Cytokines and the Bone Marrow: New Concepts on the Pathogensis of Osteoporosis”, Non-Reproductive Actions of Sex Steroids, Ciba Foundation Symposium 191, p. 187-202, 1995.
Martin “Hormones in the Coupling of Bone Resorption and Formation”, Osteoporosis International, Suppl. 1: S121-S125, 1993.
Leushner et al. “Automated Mass Spectrometry: A Revolutionary Technology for Clinical Diagnostics”, Molecular Diagnosis, 5(4): 341-348, 2000.
Matsuda et al. “Structure of A Cannabinoid Receptor and Functional Expression of the Cloned cDNA”, Nature, 346: 561-564, 1990.
Mauler et al. “BAY 38-7271: A Novel Highly Selective and Highly Potent Cannabinoid Receptor Agonist for the Treatment of Traumatic Brain Injury”, CNS Drug Reviews, 9(4): 343-358, 2003.
McKallip et al. “Targeting CB2 Cannabinoid Receptor as A Novel Therapy to Treat Malignant Lymphblastic Disease”, Blood, 100(2): 627-634, 2002.
Müller et al. “Micro-Tomographic Imaging for the Nondestructive Evaluation of Trabecular Bone Architecture”, Bone Research in Biomechanics, p. 61-79, 1997.
Munro et al. “Molecular Characterization of A Peripheral Receptor for Canabinoids”, Nature, 365: 61-65, 1993.
Nickerson et al., “Automated DNA Diagnostics Using An ELISA-Based Oligonucleotide Ligation Assay”, Proc. Natl. Acad. Sci. USA, 87: 8923-8927, 1990.
O'Meara et al. “SNP Typing by Apyrase-Mediated Allele-Specific Primer Extension on DNA Microarrays”, Nucleic Acids Research, 30(15/e75): 1-8, 2002.
Orita et al. “Rapid and Sensitive Detection of point Mutations and DNA Polymorphisms Using the Polymerase Chain Reaction”, Genomics, 5: 874-879, 1989.
Pack et al. “Improved Bivalent Miniantibodies, With Identical Avidity as Whole Antibodies, Produced by High Cell Density Fermentation ofEscherichia coli”, Bio/Technology, 11: 1271-1277, 1993.
Parfitt et al. “Bone Histomorphometry: Standartization of Nomenclature, Symbols, and Units”, Journal of Bone and Mineral Research, 2(6): 595-610, 1987.
Porter “The Hydrolysis of Rabbit γ-Globulin and Antibodies With Crystalline Papain”, The Biochemical Journal, 73: 119-126, 1959.
Rao et al. “Genotyping Single Nucleotide Polymorphisms Directly From Genomic DNA by Invasive Cleavage Reaction on Microspheres”, Nucleic Acids Research, 31(11/e66): 1-8, 2003.
Ren et al. “Straightforward Detection of SNPs in Double-Stranded DNA by Using Exonuclease III/Nuclease S1/PNA System”, Nucleic Acids Research, 32(4/e42): 1-9, 2004.
Risch et al. “The Future of Genetic Studies of Complex Human Diseases”, Science, 273(5281): 1516-1517, 1996.
Ross et al. “Inhibition of Nitric Oxide Production in RAW264.7 Macrophages by Cannabinoids and Plamitoylethanolamide”, European Journal of Pharmacology, 401: 121-130, 2000.
Rubin et al. “IGF-I Regulates Osteoprotegerin (OPG) and Receptor Activator of Nuclear Factor-κB Ligand In Vitro and OPG In Vivo”, The Journal of Clinical Endocrinology & Metabolism, 87(9): 4273-4279, 2002.
Sauer et al. “Extension of the GOOD Assay for Genotyping Single Nucleotide Polymorphisms by Matrix -Assisted Laser Desorption/Ionization Mass Spectrometry”, Rapid Communications in Mass Spectrometry, 17: 1265-1272, 2003.
Scholz et al. “Rapid Screening for Tp53 Mutations by Temperature Gradient Gel Electrophoresis: A Comparison With SSCP Analysis”, Human Molecular Genetics, 2(12): 2155-2158, 1993.
Sheffield et al. “Attachment of A 40-Base-Pair G+C-Rich Sequence (CG-Clamp) to Genomic DNA Fragments by the Polymerase Chein Reaction Results in Improved Detection of Single-Base Changes”, Proc. Natl. acad. Sci. USA, 86: 232-236, 1989.
Shi “Enabling Large-Scale Pharmacogenetic Studies by High-Throughput Mutation Detection and Genotyping Technologies”, Clinical Chemistry, 47(2): 164-172, 2001.
Shire et al. “An Amino-Terminal Variant of the Central Cannabinoid Receptor Resulting From Alternative Splicing”, The Journal of Biological Chemistry, 270(8): 3726-3731, 1995.
Slatkin et al. “Testing for Linkage Disequilibrium in Genotypic Data Using the Expectation-Maximization Algorithm”, Heredity, 76: 377-383, 1995.
Smith et al. “Novel Method of Detecting Single Base Substitutions in RNA Molecules by Differential Melting Behavior in Solution”, Genomics, 3: 217-223, 1988.
Solinas et al. “Duplex Scorpion Primers in SNP Analysis and FRET Applications”, Nucleic Acids Research, 29(20/e96): 1-9, 2001.
Tõnisson et al. “Unravelling Genetic Data by Arrayed Primer Extension”, Clin. Chem. Lab. Med., 38(2): 165-170, 2000.
Turner et al. “Typing of Multiple Single Nucleotide Polymorphisms in Cytokine and Receptor Genes Using SNaPshot”, Human Immunology, 63: 508-513, 2002.
Wartell et al. “Detecting Base Pair Substitutions in DNA Fragments by Temperature-Gradient Gel Electrophoresis”, Nucleic Acids Research, 18(9): 2699-2705, 1990.
Whitlow et al. “Single-Chain Fv Proteins and Their Fusion Proteins”, Methods: A Companion to Methods in Enzymology, 2(2): 97-105, 1991.
Liu et al. “Molecular Studies of Identification of Genes for Osteoporosis: The 2002 Update”, Journal of Endocrinology, 177: 147-196, 2003.
Zou et al. “CpG Oligonucleotides: Novel Regu
Bab Itai
De Vernejoul Marie-Christine
Karsak Meliha
Mechoulam Raphael
Shohami Esther
Bausch Sarae
Institut National de la Sante et de la Recherche Medicale
Karsak Meliha
Shaw Amanda
Yissum Research Development Company of the HebrewUniversityofJer
LandOfFree
Methods, kits and pharmaceutical compositions for... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods, kits and pharmaceutical compositions for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods, kits and pharmaceutical compositions for... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4011924